ATE350054T1 - Pharmazeutische kombinationspräparate zur krebstherapie enthaltend glutaminase und antineoplastische anthracycline oder platinverbindungen - Google Patents
Pharmazeutische kombinationspräparate zur krebstherapie enthaltend glutaminase und antineoplastische anthracycline oder platinverbindungenInfo
- Publication number
- ATE350054T1 ATE350054T1 AT04739811T AT04739811T ATE350054T1 AT E350054 T1 ATE350054 T1 AT E350054T1 AT 04739811 T AT04739811 T AT 04739811T AT 04739811 T AT04739811 T AT 04739811T AT E350054 T1 ATE350054 T1 AT E350054T1
- Authority
- AT
- Austria
- Prior art keywords
- cancer therapy
- pharmaceutical combination
- platinum compounds
- combination preparations
- therapy containing
- Prior art date
Links
- 102000009127 Glutaminase Human genes 0.000 title abstract 3
- 108010073324 Glutaminase Proteins 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 3
- 229940045799 anthracyclines and related substance Drugs 0.000 title 1
- 230000000118 anti-neoplastic effect Effects 0.000 title 1
- 229940045985 antineoplastic platinum compound Drugs 0.000 title 1
- 238000011275 oncology therapy Methods 0.000 title 1
- 150000003058 platinum compounds Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 2
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 229940034982 antineoplastic agent Drugs 0.000 abstract 1
- 239000000824 cytostatic agent Substances 0.000 abstract 1
- 230000001085 cytostatic effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
- 230000004614 tumor growth Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10326821A DE10326821A1 (de) | 2003-06-11 | 2003-06-11 | Pharmazeutische Kombinationspräparate zur Krebstherapie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE350054T1 true ATE350054T1 (de) | 2007-01-15 |
Family
ID=33495036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04739811T ATE350054T1 (de) | 2003-06-11 | 2004-06-11 | Pharmazeutische kombinationspräparate zur krebstherapie enthaltend glutaminase und antineoplastische anthracycline oder platinverbindungen |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060263346A1 (https=) |
| EP (1) | EP1633394B1 (https=) |
| JP (1) | JP2006527232A (https=) |
| AT (1) | ATE350054T1 (https=) |
| AU (1) | AU2004244755B9 (https=) |
| CA (1) | CA2528897A1 (https=) |
| DE (2) | DE10326821A1 (https=) |
| ES (1) | ES2280972T3 (https=) |
| WO (1) | WO2004108153A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8465736B2 (en) | 2006-05-10 | 2013-06-18 | New Medical Enzymes Ag | Glutadon |
| US8173686B2 (en) | 2006-11-06 | 2012-05-08 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8168661B2 (en) | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8168662B1 (en) | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8178564B2 (en) | 2006-11-06 | 2012-05-15 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| EP2047858A1 (en) * | 2007-10-10 | 2009-04-15 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Combination products for treating cancer |
| CA2934700A1 (en) | 2014-01-06 | 2015-07-09 | Rhizen Pharmaceuticals Sa | Glutaminase inhibitors |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020094542A1 (en) * | 1988-04-15 | 2002-07-18 | Peter Leskovar | Drugs and methods for treating cancer |
| US4955857A (en) * | 1988-07-18 | 1990-09-11 | Shettigar Udipi R | Multi-enzyme bioreactor therapy for cancer |
| US5776458A (en) * | 1990-12-05 | 1998-07-07 | Pharmacia & Upjohn S.P.A. | Anthracycline-conjugates |
| DE4140003C2 (de) * | 1991-12-04 | 1994-09-29 | Joseph Prof Dr Roberts | Gentechnisch hergestellte Glutaminase und ihre Verwendung bei der antiviralen und Anti-Krebstherapie |
| DE69233695T2 (de) * | 1992-12-04 | 2008-01-24 | Me Medical Enzymes Ag | Gentechnologisch hergestellte glutaminase und ihre verwendung in therapie |
| EP0613899B1 (en) * | 1993-03-04 | 2003-01-15 | Matsushita Electric Industrial Co., Ltd. | Cocaine derivative, protein conjugate thereof, monoclonal antibody producing hybridoma cell line, method for preparing the hybridoma cell line and monoclonal antibody |
| US20020115609A1 (en) * | 1997-07-14 | 2002-08-22 | Hayat Onyuksel | Materials and methods for making improved micelle compositions |
| US6200754B1 (en) * | 1998-03-19 | 2001-03-13 | Variagenics, Inc. | Inhibitors of alternative alleles of genes encoding products that mediate cell response to environmental changes |
| EP1451343B1 (en) * | 2001-11-02 | 2012-10-17 | Dana-Farber Cancer Institute | Methods and compositions for the diagnosis of cancer susceptibilities and defective dna repair mechanisms and treatment thereof |
| DE60217532T8 (de) * | 2001-11-07 | 2008-02-07 | Millennium Pharmaceuticals, Inc., Cambridge | Carboline derivate als ikb-inhibitoren zur behandlung des m ultiplen myelomas |
-
2003
- 2003-06-11 DE DE10326821A patent/DE10326821A1/de not_active Ceased
-
2004
- 2004-06-11 CA CA002528897A patent/CA2528897A1/en not_active Abandoned
- 2004-06-11 ES ES04739811T patent/ES2280972T3/es not_active Expired - Lifetime
- 2004-06-11 JP JP2006515900A patent/JP2006527232A/ja active Pending
- 2004-06-11 WO PCT/EP2004/006320 patent/WO2004108153A1/de not_active Ceased
- 2004-06-11 AU AU2004244755A patent/AU2004244755B9/en not_active Ceased
- 2004-06-11 US US10/560,317 patent/US20060263346A1/en not_active Abandoned
- 2004-06-11 DE DE502004002561T patent/DE502004002561D1/de not_active Expired - Lifetime
- 2004-06-11 AT AT04739811T patent/ATE350054T1/de active
- 2004-06-11 EP EP04739811A patent/EP1633394B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1633394B1 (de) | 2007-01-03 |
| EP1633394A1 (de) | 2006-03-15 |
| AU2004244755B9 (en) | 2009-12-24 |
| DE502004002561D1 (de) | 2007-02-15 |
| US20060263346A1 (en) | 2006-11-23 |
| ES2280972T3 (es) | 2007-09-16 |
| WO2004108153A1 (de) | 2004-12-16 |
| JP2006527232A (ja) | 2006-11-30 |
| CA2528897A1 (en) | 2004-12-16 |
| AU2004244755A1 (en) | 2004-12-16 |
| AU2004244755B2 (en) | 2009-06-25 |
| DE10326821A1 (de) | 2005-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0608297A2 (pt) | composições de lipossomos | |
| MX383644B (es) | Combinaciones y metodos de administracion de agentes terapeuticos y terapia de combinacion. | |
| BRPI0413427A (pt) | derivados de piridilpirrol ativos como inibidores da cinase | |
| BRPI0416981A (pt) | compostos para tratamento de doenças proliferativas de célula | |
| BR0315688A (pt) | Compostos, composições farmacêuticas e seus usos no tratamento ou prevenção de doenças ou condições de proliferação celular metabólicas | |
| EA200702239A1 (ru) | Уничтожение гетерогенной или смешанной клеточной популяции в опухолях | |
| FR2869231B1 (fr) | Composition therapeutique contenant au moins un derive de la pyrrolobenzodiazepine et la fludarabine | |
| BRPI0207961B8 (pt) | uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos. | |
| PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
| EP2574341A8 (en) | Effective treatment of tumors and cancer with triciribine and related compounds | |
| EA200602047A1 (ru) | Сульфонилэтилфосфородиамидаты, предназначенные для применения при лечении рака | |
| EA200600424A1 (ru) | Применение полипептидов семейства купредоксинов при лечении рака | |
| BRPI0514721A (pt) | uso de compostos de peptìdeos para tratar dor de cáncer ósseo, dor induzida por quimioterapia e nucleosìdeo | |
| BRPI0413438A (pt) | derivados de pirimidilpirrol ativos como inibidores de cinase | |
| BRPI0410663B8 (pt) | compostos de hidroxiamidina e hidroxiguanidina e seus usos | |
| AR053338A1 (es) | Terapia antiproliferativa combinada usando ciertos agentes quimioterapeuticos basados en platino y taxanos | |
| NO20055838L (no) | Aktive varianter av IL-18 bindende protein og medisinske anvendelser derav | |
| SE0300098D0 (sv) | Use of cyclin D1 inhibitors | |
| ATE350054T1 (de) | Pharmazeutische kombinationspräparate zur krebstherapie enthaltend glutaminase und antineoplastische anthracycline oder platinverbindungen | |
| GT200200279A (es) | Anticuerpo que inhibe la actividad del factor de las celulas precursoras y su uso para el tratamiento del asma | |
| UA87877C2 (en) | Pegylated liposomal doxorubicin in combination with ecteinescidin 743 | |
| MX2008008556A (es) | Derivados de triterpenoquinonas y triterpenofenoles y su aplicacion para el tratamiento de tumores y enfermedades parasitarias. | |
| WO2001041747A3 (de) | Pharmazeutische zubeteitung enthaltend zytostatika und electronenakzeptoren zur behandlung von krebs | |
| WO2006113579A3 (en) | Tumor inhibition by modulating sprouty expression or activity | |
| ATE545421T1 (de) | Pharmazeutisches präparat zur behandlung von parasitären tropenkrankheiten enthaltend diminazen-di-aceturat |